Skip to content

V-CHECK

Midwife counselling programme to increase cervical cancer screening attendance. Verloskundige Counseling en Educatie in HPV en Cervicale Kanker Screening - V-CHECK

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58568
Enrollment
600
Registered
2026-03-16
Start date
2026-06-05
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer Cervical cancer

Interventions

In&nbsp
first&nbsp
stage,&nbsp
we&nbsp
prepare&nbsp
implement&nbsp
a&nbsp
longitudinal,&nbsp
cluster-randomized&nbsp
controlled&nbsp
trial.&nbsp
Midwifery&nbsp
practices and&nbsp
obstetric&nbsp
providers&nbsp

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1: Age 30 years or above 2: Non-compliant with cervical cancer population screening (‘non-attenders’) with an invitation during one, two or theoretically three rounds (‘un- or under screened’) 3: Informed consent. 

Exclusion criteria

Exclusion criteria: 1: Age <30 years 2: Attending cervical cancer population screening according to invitation 3: Recent (< 1 year) cervical PAP smear for other indication Midwives who participate in the study are also asked to guard logbook information and join focus groups. For this group, the only inclusion criterium is that the e-learning is successfully completed in advance. 

Design outcomes

Primary

MeasureTime frame
Measure screening participation among postpartum women by comparing those who received counselling with those who did not.Assess long-term effectiveness, cost-effectiveness, and feasibility of the counselling programme.Evaluate the impact of counselling on:Informed decision-makingScreening outcomes

Secondary

MeasureTime frame
Identify factors affecting compliance or non-compliance with colposcopy or follow-up care after an HPV-positive result.Track CIN2+ detection after participation.Evaluate barriers and feasibility of implementing the programme, including obstacles to participation.Assess the long-term impact of counselling on future screening attendance.Examine the programme's impact on cervical cancer incidence and mortality in the coming decades.

Countries

Netherlands

Contacts

Public ContactR.L.O. Laar

Erasmus MC, Universitair Medisch Centrum Rotterdam

V-CHECK@erasmusmc.nl010-704 07 04

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026